{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T23:00:45Z","timestamp":1767913245983,"version":"3.49.0"},"reference-count":15,"publisher":"Japanese Society of Internal Medicine","issue":"18","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2012]]},"DOI":"10.2169\/internalmedicine.51.7204","type":"journal-article","created":{"date-parts":[[2012,9,15]],"date-time":"2012-09-15T01:02:16Z","timestamp":1347670936000},"page":"2597-2602","source":"Crossref","is-referenced-by-count":12,"title":["Low-Density Lipoprotein Apheresis Therapy for Steroid- and Cyclosporine-Resistant Idiopathic Membranous Nephropathy"],"prefix":"10.2169","volume":"51","author":[{"given":"Yoshinori","family":"Sato","sequence":"first","affiliation":[{"name":"Division of Nephrology, Department of Internal Medicine, Showa University Fujigaoka Hospital, Japan"},{"name":"Department of Internal Medicine, Yokohama Sakae Kyosai Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichiro","family":"Tsunoda","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Medicine, Hyogo Medical School, Japan"},{"name":"Department of Internal Medicine, Yokohama Sakae Kyosai Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsuyoshi","family":"Nozue","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Yokohama Sakae Kyosai Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qinya","family":"Pan","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Yokohama Sakae Kyosai Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harue","family":"Wakasugi","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Yokohama Sakae Kyosai Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashio","family":"Yoshimura","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Internal Medicine, Showa University Fujigaoka Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","unstructured":"1. Fervenza FC, Sethi S, Specks U. Idiopathic membranous nephropathy: Diagnosis and treatment. Clin J Am Soc Nephrol 3: 905-919, 2008."},{"key":"2","unstructured":"2. Polanco N, Gutiérrez E, Covarsí A, et al. Spontaneous remission of nephrotic syndrome in idiopathic membranous nephropathy. J Am Soc Nephrol 21: 697-704, 2010."},{"key":"3","unstructured":"3. Cattran DC, Appel GB, Hebert LA, et al. Cyclosporine in patients with steroid-resistant membranous nephropathy: a randomized trial. Kidney Int 59: 1484-1490, 2001."},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Pei Y, Cattran D, Greenwood C. Predicting chronic renal insufficiency in idiopathic membranous glomerulonephritis. Kidney Int 42: 960-966, 1992.","DOI":"10.1038\/ki.1992.374"},{"key":"5","unstructured":"5. Cattran DC, Pei Y, Greenwood CM, Ponticelli C, Passerini P, Honkanen E. Validation of a predictive model of idiopathic membranous nephropathy: its clinical and research implications. Kidney Int 51: 901-907, 1997."},{"key":"6","unstructured":"6. Muso E, Yashiro M, Matsushima M, Yoshida H, Sawanishi K, Sasayama S. Does LDL-apheresis in steroid-resistant nephrotic syndrome affect prognosis? Nephrol Dial Transplant 9: 257-264, 1994."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Hattori M, Chikamoto H, Akioka Y, et al. A combined low-density lipoprotein apheresis and prednisone therapy for steroid-resistant primary focal segmental glomerulosclerosis in children. Am J Kidney Dis 42: 1121-1130, 2003.","DOI":"10.1053\/j.ajkd.2003.08.012"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Kobayashi T, Ando Y, Umino T, et al. Complete remission of minimal-change nephrotic syndrome induced by apheresis monotherapy. Clin Nephrol 65: 423-426, 2006.","DOI":"10.5414\/CNP65423"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Petrichenko I, Daret D, Larrue J, Shakhov Y. Effect of VLDL on the inhibition of arachidonic acid transformation by dexamethasone in cultured smooth muscle cells. Biochim Biophys Acta 1166: 183-187, 1993.","DOI":"10.1016\/0005-2760(93)90095-Q"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. de Groen PC. Cyclosporine, low-density lipoprotein, and cholesterol. Mayo Clin Proc 63: 1012-1021, 1988.","DOI":"10.1016\/S0025-6196(12)64916-7"},{"key":"11","unstructured":"11. Loichot C, Bentue-Ferrer D, Bernard N, et al. Cyclosporine monitoring in renal transplant recipients with induction therapy: C2 levels in patients monitored on C0. Fundam Clin Pharmacol 20: 91-96, 2006."},{"key":"12","unstructured":"12. Stenvinkel P, Alvestrand A, Angelin B, Eriksson M. LDL-apheresis in patients with nephrotic syndrome: effects on serum albumin and urinary albumin excretion. Euro Jour of Cli Invest 30: 866-870, 2000."},{"key":"13","unstructured":"13. Ideura T, Hora K, Kaneko Y, et al. Effect of low-density lipoprotein-apheresis on nephrotic syndrome due to membranous nephropathy in renal allograft: a case report. Transplant Proc 32: 223-226, 2000."},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Muso E, Mune M, Yorioka N, et al. Beneficial effect of low-density lipoprotein apheresis (LDL-A) on refractory nephrotic syndrome (NS) due to focal glomerulosclerosis (FGS). Clin Nephrol 67: 341-344, 2007.","DOI":"10.5414\/CNP67341"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Ueda S, Sugimoto K, Yanagida H, et al. Low-density lipoprotein adsorption therapy can restore drug sensitivity for immunosuppressants via inhibitory effects upon MDR-1 gene expression. Ther Apher Dial 15: 499-503, 2011.","DOI":"10.1111\/j.1744-9987.2011.00984.x"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/51\/18\/51_51.7204\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T17:43:40Z","timestamp":1621446220000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/51\/18\/51_51.7204\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012]]},"references-count":15,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.51.7204","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012]]}}}